if 273 doesnt get accelerated approval, they might as well end the program....fits every criterion to a T
closed last Friday at $1.34....closed today at $1.37....only moved 3 cents this week. Need to get Wall Street back from vacationing in the Hamptons.
the game on display today
What else kills solid tumors with minimal side-effects? ADXS's vaccines are also effective on solid tumors. But your question is a good one, there are very few effective immunotherapies for solid tumors. And this stock is so undervalued it could have the kind of run ADXS had 9 months ago.
Jbem does his homework. This one is very undervalued and has news coming that should move it. Same as with AVXL, the best pick so far, which has risen a lot, but still is hugely undervalued and will have major news this fall when P2 completed. Very generous of jbem to share such high quality work.
Every so often a bear raid is held to steal the shares of the weak hands. A bunch of bashers show up, start sowing doubts and fear, a wave of shorting starts, and those who question themselves sell cheap. If you sold at $1 today, you gypped yourself out of a 20% gain. Remember to ask yourself if there is any real news moving the stock. If not, ignore the buzz and hang on to your shares. Dont get played.